What is Beximco Pharmaceuticals Revenue per Share?
Beximco Pharmaceuticals's revenue per share for the
three
months ended in Dec. 2023 was BDT24.44.
Beximco Pharmaceuticals's revenue per share for the trailing twelve months (TTM) ended in Dec. 2023 was BDT68.35.
Good Sign:
Beximco Pharmaceuticals Ltd has shown predictable revenue and earnings growth.
During the past 12 months, the average Revenue Per Share Growth Rate of Beximco Pharmaceuticals was 12.20% per year.
During the past 3 years, the average Revenue Per Share Growth Rate was 15.30% per year.
During the past 5 years, the average Revenue Per Share Growth Rate was 16.60% per year.
During the past 10 years, the average Revenue Per Share Growth Rate was 16.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.
The historical rank and industry rank for Beximco Pharmaceuticals's Revenue per Share or its related term are showing as below:
DHA:BXPHARMA'
s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -12.3 Med: 15.3 Max: 24.7
Current: 15.3
During the past 13 years, Beximco Pharmaceuticals's highest 3-Year average Revenue Per Share Growth Rate was 24.70% per year. The lowest was -12.30% per year. And the median was 15.30% per year.
DHA:BXPHARMA's 3-Year Revenue Growth Rate is ranked better than 76.25% of 922
companies
in the Drug Manufacturers industry
Industry Median: 6.4
vs DHA:BXPHARMA: 15.30
Beximco Pharmaceuticals Revenue per Share Historical Data
The historical data trend for Beximco Pharmaceuticals's Revenue per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Beximco Pharmaceuticals's Revenue per Share
For the Drug Manufacturers - Specialty & Generic subindustry, Beximco Pharmaceuticals's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Beximco Pharmaceuticals's PS Ratio Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Beximco Pharmaceuticals's PS Ratio distribution charts can be found below:
* The bar in red indicates where Beximco Pharmaceuticals's PS Ratio falls into.
Beximco Pharmaceuticals Revenue per Share Calculation
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Beximco Pharmaceuticals's Revenue Per Share for the fiscal year that ended in Jun. 2023 is calculated as
Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT68.35
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beximco Pharmaceuticals (DHA:BXPHARMA) Revenue per Share Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Beximco Pharmaceuticals Revenue per Share Related Terms
Thank you for viewing the detailed overview of Beximco Pharmaceuticals's Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Beximco Pharmaceuticals (DHA:BXPHARMA) Business Description
Beximco Pharmaceuticals Ltd is engaged in manufacturing and marketing a wide range of generic pharmaceutical formulation products, life-saving intravenous fluids, therapeutic nutrition products, and Active Pharmaceutical Ingredients. It manufactures various pharmaceutical products including oral contraceptives, hormones, steroids, anti-histamine, anti-fibrinolytic, cardiac, musculoskeletal, respiratory, vitamin & mineral supplements, women's health products, and others. The products of the company are sold in domestic and international markets. Key revenue accrues from local sales.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
DHA:BXPHARMA has been successfully added to your 